Commercialization: Page 112
-
PharmaVoice Team/PharmaVoice
Integration Architects: The Bridge to Peak Technological Solutions
Integration Architects: The Bridge to Peak Technological Solutions One critical and often overlooked member of the core project team is the integration architect, who defines and translates key information across technology applications. Yet many organizations do not explicitly define these posit...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Letters Informative DTC ads still have a long way to go. Hold the dogs, skateboards, straw hats, happy motorcycling couples, and all those grandkids. — Carol Bohach, B.S.Pharm. Clinical Research Consultant November 2003 Advertising and patient education need to join hands Back in the 1980s, I wro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Colin J. Foster In the Aftermath of September 11, U.S. Security is A New Reason to Improve Science Education Innovations in science and technology have long been synonymous with economic prosperity. On the other hand, it’s probably safe to say that science and technology and the st...
By Colin J. Foster • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Outsourcing: A Vital Clinical Strategy
Outsourcing: A Vital Clinical Strategy A large, unmet need exists for improved research and development productivity within pharmaceutical and biotechnology companies. Outsourcing discovery research, clinical trials, and formulation manufacturing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DTC: The Next Phase
In light of FDA guidances, more public scrutiny, and trending corporate citizenship, DTC advertising is subtly shifting to direct-to-education. Direct-to-consumer advertising has been mainly focused on creating brand awareness for major blockbuster products, or creating awareness for new therapeu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Ideology Vs. Science: The Stem-Cell Battle
Ideology Vs. Science: The Stem-Cell Battle By Kim Ribbink Across the globe, scientists are extolling the potential of stem- cell research to cure debilitating diseases, in spite of limits on federal funding as well as controversy surrounding the research. States and private investors have begun t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Jean-Louis Anspach Michael R. Dornhecker Ann Willmoth Solvay Pharmaceuticals Announces Key Promotions Solvay Pharmaceuticals, Marietta, Ga., has named Jean-Louis Anspach as VP, commercial operations, responsible for managing all aspects of the primary-care business unit, including sal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Flying High On A Vision
Flying High on a Vision By Kim Ribbink Entrepreneurs are individuals who make innovation possible; they are the people who stake their reputation, finances, and future on running their own businesses and achieving something different. As pharmaceutical and service companies continue to merge, bus...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Continuing Evolution of EDC
Paper may still reign supreme, but the EDC industry is coming of age. There is widespread agreement — at least intuitively — that the use of an electronic device or software application that allows direct data entry into electronic format has the potential to reduce time and money within the drug...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Michael J. DuBois Jeffrey A. Winton Schering-Plough Announces VP Appointments Schering-Plough, Kenilworth, N.J., has appointed Michael J. DuBois senior VP of global licensing. In this role, Mr. DuBois, 56, is responsible for the acquisition of new products discovered outside Schering-...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE June 2005 Letter from the Editor In 1990, some very smart women realized that to effect change in the industry, HBA was going to have to take an active role in recognizing women in leadership positions and increasing their visibility in the industry. “Since then, we have been recogniz...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on Your Mind — Opinions Opinions Blogs, which often combine a mixture of what is happening in a person’s life and what is happening on the Web into a type of hybrid diary/guide site, are quickly becoming important online resources for consumers and patients. Bloggers share personal informa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
It's All About Changing Practice
It’s All About Changing Practice Each and every step along the drug-development path must focus on the end game — to define the place of a new drug in practice, and then to communicate the data clearly and consistently using all available channels. But can companies make themselves heard in th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating a Guidance System for Life-Science Brands
Creating a Guidance System for Life-Science Brands While meaningful biomedical research depends on proteomics, genetics, and genomics tools, their ultimate application also will depend on successful commercialization and marketing tools. Mark Stinson President ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Personalized Medicine: Our Industry's Next Great Leap Forward
Personalized Medicine: Our Industry’s Next Great Leap Forward Marketing Personalized medicine will drive medicine to become much more of a science than an art. And with that change, there will be many necessary fundamental changes to how our industry markets these innovations. Ri...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketing Strategies for Emerging Companies: Lessons from the Maine Wilderness
Marketing Strategies for Emerging Companies: Lessons from the Maine Wilderness for Biotech and Biopharma I do not consider a sale complete until the goods are worn out and the customer (sic) is still satisfied.” When Leon Leonwood Bean posted those words in his humble Maine store in 1916 he wa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Branding Your Company -- Right from the Start
Branding Your Company — Right from the Start Executives of emerging biotech companies face myriad challenges. While they may certainly understand the value of branding and marketing, those functions may command less of their attention during the early stages of company development than the challe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Giving Birth to a Healthy Brand
Joseph Doyle, R.Ph. Chief Branding and Strategy Officer Giving Birth to a Healthy Brand the promotional mix Closely aligning clinical and marketing strategies early in development is the way to ensure that a brand will be born healthy. It seems that no matter what the br...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Getting Back to the Basics of Pharmaceutical Marketing
The Creative Process Getting Back to the Basics of Pharmaceutical Marketing Christine Yanicek Interactive Content Director When a product has a novel mechanism of action or breakthrough technology, it is going to take more than the right image to place a pro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Giving Birth to a Healthy Brand
The Promotional Mix Closely aligning clinical and marketing strategies early in development is the way to ensure that a brand will be born healthy. Joseph Doyle, R.Ph. Chief Branding and Strategy Officer It seems that no matter what the branding process is — even with the best pro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Technology for Implementing Targeted Media
The Promotional Mix Technology for Implementing Targeted Media In a highly competitive market, a well-detailed brand needs interstitial messaging through nonpersonal media channels at a minimum frequency of 24 times between every det...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Rational Marketer's Approach to Target Identification
The Promotional Mix The Rational Marketer’s Approach to Target Identification Target selection is becoming increasingly complex for today’s pharmaceutical marketer. Not that long ago, the world was much simpler. Mark S. Perlotto Executive VP, Chief Marketing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Role of Independent Agencies
The Role of Independent Agencies Never has our industry valued or embraced the independent agency as it does now. Part of the reason for this is the backlash created from the aggressive mergers and acquisitions during the past 10 years. Pharmaceutical clients have begun to seriously ask large ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating and Sustaining a Meaningful Agency Culture: Where Style Meets Substance
Creating and Sustaining a Meaningful Agency Culture: Where Style Meets Substance A strong agency culture gives everyone the confidence to remain open-minded and to look at business issues from all perspectives. It’s what draws smart people to an agency ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Freedom of Choice: Partnering with Complementary Competencies
Freedom of Choice: Partnering with Complementary Competencies Patricia Malone Principal, Creative Services Susan Hempstead Principal, Account Services Paul Harris Principal, Creative Services Clients can benefit from unique and effective strategies from complementary partners; ...
By PharmaVoice Team • Jan. 2, 2008
Previous
